Clinical trial
Preventing Cognitive Decline with Metformin:: the MetMemory Study
NCT04511416 is registered in ClinicalTrials.gov with Garvan Institute of Medical Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Preventing Cognitive Decline with Metformin:: the MetMemory Study
- Lead sponsor
- Garvan Institute of Medical Research
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- July 15, 2022
- Completion date
- December 31, 2027
- Enrollment
- 242 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cognitive decline